Episode of acute pancreatitis with gland inflammation, exudates and eventual disruption of. Recurrent nerve; Vn, vagus nerve; O, oesophagus a b. The sliding, wide visceral pleura (1) is an artefact caused by total reflection at. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Zurowski D, Nowak L, Wordliczek J, Dobrogowski J, Thor PJ. Effects of vagus nerve stimulation in visceral pain model. Sinniger V and Pellissier S (2017) The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the. Vagus Nerve have launched a Kickstarter campaign to fund their first EP, set to be titled Visceral, to which you can contribute here. Perks include the usual assortment of options: digital downloads, CDs, t-shirts, posters, signed items, guitar lessons, and so on and so forth. “Visceral”, the debut EP from VAGUS NERVE, can be streamed in its entirety using the SoundCloud widget below. Starting as a passion project of ex-GOD FORBID guitarist Doc Coyle and PHYLLOTAXIS singer-songwriter Ravi Orr, VAGUS NERVE became fully realized as a band in 2014 when they enlisted the talents of drummer Moe Watson (SHAI HULUD), []. (2017) Low-level vagus nerve stimulation suppresses post-operative atrial fibrillation and inflammation: a randomized study. J Am Coll Cardiol EP 3: 929 – 938.
Brain Behav Immun. Author manuscript; available in PMC 2015 May 1.
Published in final edited form as:
Published online 2013 Dec 25. doi: 10.1016/j.bbi.2013.12.015
NIHMSID: NIHMS560413
![]()
The publisher's final edited version of this article is available at Brain Behav Immun
See other articles in PMC that cite the published article.
AbstractMammals live in a co-evolutionary association with the plethora of microorganisms that reside at a variety of tissue microenvironments. The microbiome represents the collective genomes of these co-existing microorganisms, which is shaped by host factors such as genetics and nutrients but in turn is able to influence host biology in health and disease. Niche-specific microbiome, prominently the gut microbiome, has the capacity to effect both local and distal sites within the host. The gut microbiome has played a crucial role in the bidirectional gut-brain axis that integrates the gut and central nervous system (CNS) activities, and thus the concept of microbiome-gut-brain axis is emerging. Studies are revealing how diverse forms of neuro-immune and neuro-psychiatric disorders are correlated with or modulated by variations of microbiome, microbiota-derived products and exogenous antibiotics and probiotics. The microbiome poises the peripheral immune homeostasis and predisposes host susceptibility to CNS autoimmune diseases such as multiple sclerosis. Neural, endocrine and metabolic mechanisms are also critical mediators of the microbiome-CNS signaling, which are more involved in neuro-psychiatric disorders such as autism, depression, anxiety, stress. Research on the role of microbiome in CNS disorders deepens our academic knowledge about host-microbiome commensalism in central regulation and in practicality, holds conceivable promise for developing novel prognostic and therapeutic avenues for CNS disorders. 1. Introduction to microbiomeHuman beings, like other mammals, live in a co-evolutionary association with huge quantities of commensal microorganisms resident on the exposed and internal surfaces of our bodies. The entirety of microorganisms in a particular habitat is termed microbiota, or microflora. The collective genomes of all the microorganisms in a microbiota are termed microbiome(; ). Commensal microbiota and microbiome outnumber human somatic cells and genome, respectively by approximately 10-100:1 (). The microbiota composition is influenced by temporal and spatial factors. Temporally, the human fetal gut is sterile but colonization begins immediately after birth and is affected by route of delivery, maternal transfer, diet, environmental stimuli and antibiotic usage (). However, the presence of bacteria has been detected in the meconium from healthy neonates, which might hint the existence of prenatal mother-to-child transfer of microbiota(; ). By 1 year of age, an idiosyncratic gut microbiome with adult-like signature is stabilized in each infant(). While adult gut bacterial communities vary, the concept of enterotype has been raised to classify individuals by their gut microbiota composition. Three enterotypes were characterized in human adults with relative abundance of Bacteroides, Prevotella or Ruminococcus genus(). Yet, discrete enterotypes are still arguable as a later study revealed gradients of key bacterial genera(). Whether human gut microbiota profiles fall into distinct clusters or a continuum depends on sampling strategy and methods of analysis and entails further comparison between healthy and diseased individuals. Spatially, each body habitat is differentially dominated by specific phyla of microbiota: skin by Actinobacteria, Firmicutes and Proteobacteria; oral cavity by Bacteroidetes, Firmicutes, Fusobacteria and Proteobacteria; airway tract by Bacteroidetes, Firmicutes, and Proteobacteria; GI tract by Bacteroidetes and Firmicutes; and urogenital tract by Firmicutes (species under Lactobacillus genus)(). Adding to the complexity, there is an uneven spatial distribution of microbiota within each specific niche. In the human GI tract, the quantity and diversity of microbiota increase from stomach to small intestine and to colon(; ). Interestingly, microbiota have been identified within immune-privileged sites such as the CNS. α-proteobacteria class is reported to be the major commensals persistent in the human brain regardless of immune status(). While the host-microbiome interaction is not a novel concept, only recently has it been revisited by a surge of studies. Co-evolution has pre-determined that microbiota form a long-term symbiosis rather than short-term parasitism with human hosts. Yet, our prior and expanding knowledge about the effects of microbiome on host biology indicates that microbiota are not commensalistic bystanders that bring no benefit or detriment to hosts. Instead, a significant proportion of microbiota can be defined as symbionts or pathobionts, depending on whether they are mutualistic health-promoters or opportunistic pathology-inducers for hosts(). Host-microbiota mutualism is exemplary in the gut, where gut microbiome as a joint unity can be viewed as an organ of the host(). Traditionally, gut microbiome is considered to have three major categories of functions. First, it defends against pathogen colonization by nutrient competition and production of anti-microbial substances. Second, it fortifies intestinal epithelial barrier and induces secretory IgA (sIgA) to limit bacteria penetration into tissues. Third, it facilitates nutrient absorption by metabolizing indigestible dietary compounds. In line with these concepts, germ-free (GF) animals have higher susceptibility to infection but reduced digestive enzyme activities and muscle wall thickness(; ). Functional metatranscriptomic analysis of human fecal microbiota demonstrated a common pattern of overrepresented genes involved in carbohydrate metabolism, energy production and synthesis of cellular components (). The recent trend of research has focused on the fourth role of gut microbiome: guiding maturation and functionality of the host immune system. Immune defects in GF mice are evident at both structural levels, such as decreased peyer's patches, lamina propria and isolated lymphoid follicles, and at cellular levels, such as decreased intestinal CD8+ T cells and CD4+ T helper 17 (Th17) cells and reduced B cell production of secretory IgA (sIgA)(). Th17 cells are potent mediators of mucosal immunity that produce signature cytokine IL-17, and sIgA is the principal immunoglobulin at mucosal sites that maintains barrier functions(; ). Other immune subsets, such as Foxp3+ regulatory CD4+ T cells (Tregs), invariant natural killer T (iNKT) cells and innate lymphoid cells (ILCs), are functionally affected by microbiota at pathological conditions(; ; ). Re-colonization of GF mice with a model gut commensal, Bacteroides fragilis, restored immune maturation at gut associated lymphoid tissues. Further, purified B. fragilis capsular polysaccharide A (PSA) was sufficient to expand splenic total CD4+ T cells and intestinal Foxp3+CD4 Tregs, which suggested that specific commensal antigens could drive immune regulation(; ). Gut microbiome provides diverse signals for tuning host immune status toward either effector or regulator direction, and is thus critical to peripheral immune education and homeostasis. Microbiome at a specific niche can cast local as well as systemic effects on host biology. Disruption of a balanced composition of gut microbiome (termed dysbiosis) may cause chronic low-grade intestinal inflammation as seen in the irritable bowel syndrome (IBS) or intense intestinal autoimmunity as seen in the inflammatory bowel disease (IBD)(; ). Dietary change can bring symptomatic improvement in IBS patients. Moreover, gut microbiome alteration was observed in IBS patients, exemplified by the reduction of species under Lactobacillus genus and Clostridium class(; ). Similarly, IBD patients showed elevated antibody titers against indigenous bacteria, a drastic change of gut microbiome, and favorable response to antibiotic intervention(; ). Importantly, while genetic factors such as polymorphisms in NOD2 (nucleotide-binding oligomerization domain 2) influence susceptibility to IBD, animal studies show that dysbiosis alone suffice to induce IBD. Antibiotic depletion of microbiota cured intestinal inflammation in Tbx21-/-Rag-/- (TRUC) mice that lacked adaptive immunity and developed spontaneous IBD. Further, wild-type mice co-housed with TRUC littermates developed similar colitis symptoms(). Thus in the case of IBD, dysbiosis can directly lead to aberrant mucosal immunity, which in turn might maintain or exacerbate dysbiosis. On the other hand, beneficial gut bacteria can ameliorate IBD in both human studies and mouse models. Bifidobacteria, Lactobacillus and Bacteroides genera are the major components of beneficial probiotics(). Gut microbiota-derived products and metabolites, such as B. fragilis PSA and short-chain fatty acids (SCFA), also exerted potent anti-inflammatory functions in mouse IBD models(; ). Systemically, gut microbiome contributes to the etiology of experimental disease models affecting remote organ systems. This can be caused by the trafficking of immune cells stimulated at the intestinal site, including microbe-sensing APCs and adaptive immune cells, to distal tissue sites, by systemic diffusion of commensal microbial products or metabolites, or by bacterial translocation as a result of impaired barrier integrity. At the liver sites, endotoxemia-induced inflammation is responsible for diseases such as cirrhosis(). At the airway mucosal sites, antibiotic modulation of gut commensals impaired protective anti-viral immunity during intranasal infection with influenza and systemic infection with lymphocytic choriomeningitis virus (LCMV)(; ). Gut microbiome influences various extra-intestinal autoimmune conditions as illustrated in murine models. Germ-free status confers a complete protection from spontaneous experimental autoimmune encephalomyelitis (EAE) and ankylosing spondylitis, a partial protection from spontaneous rheumatoid arthritis (RA) yet an enhanced level of spontaneous type-1 diabetes (T1D). Further, both GF and antibiotics-treated mice showed altered severity in inducible models of extra-intestinal autoimmune diseases(; ). In this Review, we discuss the role of microbiome, especially gut microbiome, in relation to central nervous system (CNS) disorders. We analyze how microbiome liaises the bi-directional communication between gut and the critical distal site of CNS, and the mechanisms that guide each direction of function. We summarize the range of CNS disorders influenced by microbiome, which could be broadly classified into immune- and non-immune-mediated types. We further categorize the underlying microbiome-related factors implicated in CNS disorders. Our burgeoning knowledge about microbiome may provide novel avenues for therapeutics against neurological diseases. 2. Communication between gut microbiome and the CNSThe gut receives regulatory signals from the CNS and vice versa. The term gut-brain-axis thus describes an integrative physiology concept that incorporates all, including afferent and efferent neural, endocrine, nutrient, and immunological signals between the CNS and the gastrointestinal system(). As accumulating literatures underpin the importance of the gut microbiome to intestinal functions, a novel concept of microbiome-gut-brain axis has been evolved (). The core feature of this concept is bidirectional interaction, with diverse mechanisms guiding each direction of effects. If you don’t like the new subscription model, you can purchase Office at a one-time cost varying from $139.99 to $399.99. And you also get some additional features for Word Mobile on your smartphone: The cheaper Office 365 Personal package costs $6.99 per month or $69.99 per year, but supports only one user for the storage and Skype minutes, and offline installation on one computer, one tablet, and one phone. 2.1. How the CNS influences microbiomeA classical CNS-gut-microbiome signaling is operational via central regulation of satiety. Changes of dietary pattern as a result of CNS control of food intake can impact nutrient availability to gut microbiota and consequently their composition. Satiation-signaling peptides are the key molecular intermediaries that enable this downward control. These peptides, for example peptide YY (PYY), are transported through blood to the brain postprandial to exert their impact on satiety (). Satiation-signaling peptides arise primarily from the GI tract but most of them are also synthesized within the brain (reviewed by ()). Beyond that, CNS can influence gut microbiome through neural and endocrine pathways in both direct and indirect manners. The autonomic nervous system (ANS) and hypothalamus-pituitary-adrenal (HPA) axis that liaise the CNS and viscera can modulate gut physiology such as motility, secretion and epithelial permeability as well as systemic hormones, which in turn affects the niche environment for microbiota and also host-microbiome interaction at the mucosae(). Santos et al. found that stress caused epithelial barrier defects and subsequent mucosal mast cell activation(). O'Mahony et al. illustrated that an early life stress (maternal separation) increased systemic corticosterone level and immune responses and altered fecal microbiota in rats(). Bailey et al. indicated that a social disruption (SDR) initiated by co-housing with aggressive male littermates altered murine gut bacterial populations through immune-activation(). Further, release of signaling molecules, cytokines, and anti-microbial peptides (AMPs) into the gut lumen by neurons, enteroendocrine cells, immune cells and Paneth cells at the direct or indirect command of the CNS is likely to have an immediate impact on gut microbiota(). Clarke et al. discovered the QseC sensor kinase as a bacterial receptor for host-derived epinephrine and norepinephrine, which might explain the biochemical basis for host endocrine signaling to microbiota(). 2.2. How microbiome influences CNS functionsThe influence of microbiome on CNS functions is manifested in both normal and disease conditions. There is a crucial link between gut microbiome and CNS maturation under physiological state. External cues derived from indigenous commensal microbiota affect prenatal and postnatal developmental programming of the brain(; ). On the other hand, co-morbidity with mood disorders such as depression and anxiety is common in the intestinal pathological state of IBS. Chronic low-grade inflammation or immune activation that underlies the etiology of IBS is also a driving risk factor in mood disorders(). In the more intense case of IBD, co-morbidity with stress is caused by the concurrent intestinal inflammation and microbiome alteration. Change in psychological activities is perceived in patients before and after IBD diagnosis(). Upward regulation of the CNS by microbiome can be achieved through neural, endocrine, metabolic and immunological mechanisms. The neural pathway is operational through the enteric nervous system (ENS), a main division of the ANS that governs the GI functions, and vagal afferent nerves (VAN) that convey sensory information from viscera to the CNS. Probiotic modulation of gut microbiota has been shown to influence gut neuro-motor functions(). Receptors expressed on VAN sense many of the regulatory gut peptides and also information contained in dietary components, relaying the signals to the CNS afterwards(). Indeed, vagal activation is necessary for a range of effects of gut microbiome or probiotics on brain functions(). Recent studies suggest a direct interaction between gut microbiome and enteric neurons. TLR-3, 7 (recognizing viral RNA) and TLR-2, 4 (recognizing peptidoglycan and lipopolysaccharide) are expressed by the ENS in both mice and human(; ). Kunze et al. observed that Lactobacillus reuteri enhanced excitability of colonic neurons in naïve rats by inhibiting calcium-dependent potassium channel(). Mao et al. found that ex vivo, both Lactobacillus rhamnosus (strain JB-1) and B. fragilis could activate intestinal afferent neurons, while PSA completely mimicked the neuronal effects of its parent organism B. fragilis(). Chiu et al. indicated that Staphylococcus aureus activation of sensory neurons could transduce nociception(). It is still unclear, in homeostatic periods, whether and how luminal microbial antigens reach into muscularis mucosa and sub-mucosa, where the ENS resides and the physical contact with sensory neurons occurs. In the endocrinal pathway, the gut microbiome plays a major role in the development and regulation of the HPA axis that is critical to stress responses. Studies in gnotobiotic mice showed that postnatal exposure to gut microbiome affected the set point of the HPA axis(). Enteroendocrine cells interspersed among gut epithelium, particularly enterochromaffin cells, can secrete neurotransmitters and other signaling peptides in response to luminal stimuli, and thus act as transducers for the gut-endocrine-CNS route(). Besides, the vasoactive intestinal peptide (VIP), a peptide hormone synthesized in the gut but also brain, could mediate immune-modulation during CNS inflammation(). While the direct impact of microbiome on VIP expression has not been identified, dietary intervention is able to increase intestinal VIP, which might hint the role of microbiome(). Since a main function of microbiome is to facilitate host metabolism, a metabolic pathway is naturally implicit in the microbiome-gut-CNS signaling. Examples of metabolites associated with microbial metabolism or microbial–host co-metabolism have been reviewed(). Dysregulation of serotonergic and kynurenine routes of tryptophan metabolism influences the CNS pathological conditions of dementia, Huntington's disease and Alzheimer's disease(). Probiotic treatment could alter kynurenine levels and ameliorate CNS pathologies(). In addition, the metabolic pathway represents an important inter-kingdom communication as host signaling molecules can be fully synthesized or mimicked by microbiota-derived metabolites. Commensal organisms can produce a range of neuroactive molecules such as serotonin, melatonin, gamma-aminobutyric acid (GABA), catecholamines, histamine and acetylcholine(; ; ). The immunological pathway seems to be an independent mechanism in the microbiome-gut-CNS signaling. The CNS, though viewed as an immune-privileged site, is not devoid of immune cells. There is a regular presence of macrophages and dendritic cells (DCs) in the choroid plexus and meninges, microglial cells in the brain parenchyma, and leukocytes in the cerebrospinal fluid (CSF). Aberrant CNS autoimmunity arises as a consequence of direct immune disruption of neural tissues. Commensal microbiome, known to shape the host immune system, affects the auto-reactivity of peripheral immune cells to the CNS(; ). Secondly, immune-to-CNS communication is also mediated by systemic circulation of immune factors, which is implicated in neuro-psychiatric disorders such as depression. Indeed, factors that increase peripheral inflammation markers such as C-reactive protein (CRP), IL-1, IL-6 and tumor necrosis factor (TNF-a), are also risk factors for depression(; ). In both routes of the pathway, there are anti-inflammatory mechanisms that can counter-act immune-mediated CNS disease symptoms. 3. The role of microbiome in CNS disordersAs multiple mechanisms guide the impact of microbiome on the CNS, it is therefore of particular interest to explore the role of microbiome in the regulation of CNS disorders. While there is still a lack of epidemiological evidence to connect microbiome with CNS pathologies, accumulating studies have underscored the importance of microbiome in a range of CNS disorders (). CNS disorders can be classified as immune-mediated (exemplified by CNS autoimmune diseases such as multiple sclerosis) and non-immune-mediated (exemplified by neuro-psychiatric disorders such as autism, depression, anxiety and stress) according to main etiologies. This dichotomy, however, is not arbitrary since there often exists a crosstalk of etiologies. We herein summarize how microbiome can affect both categories of CNS disorders. 3.1. How microbiome affects immune-mediated CNS disorders3.1.1. Multiple sclerosisMultiple sclerosis (MS) is a chronic CNS demyelinating disease mediated by auto-reactive immune attack against central neural tissues. EAE is a widely used animal model of MS induced by CNS-restrictive antigens. Although EAE might not recapitulate all the features of human MS, it simulates its core neuro-inflammation process(). Historically, viral infection, such as Epstein-Barr virus (EBV) or human herpes virus 6, has been suggested as the trigger for human MS(). Recent studies, however, have begun to elucidate the contribution of microbiome and its relevant factors to MS pathogenesis, with much of the work investigated in EAE models(). It has been shown in MOG92-106 TCR transgenic (RR) mice that commensal microbiota are essential for the development of spontaneous EAE. Germ-free RR mice were prevented from sEAE as a result of attenuated Th17 and auto-reactive B cell responses(). Commensal microbiota are also required for induced EAE model, as GF B6 mice developed less severe EAE accompanied with decreased IFN-γ and IL-17 responses and increased Foxp3+Tregs. Segmented filamentous bacteria (SFB) colonization restored EAE susceptibility in GF mice(). Antibiotic modulation of gut microbiota controls EAE progression via diverse cellular mechanisms. Ochoa-Reparaz et al. demonstrated that IL-10-producing CD4+CD25+Foxp3+Tregs were required for oral antibiotic attenuation of EAE progression(). In a following study, Ochoa-Reparaz et al. showed that oral antibiotic treatment of EAE mice systemically induced a regulatory CD5+B cell subset(). Yokote et al. found that iNKT cells, a CD1d-restricted T cell subset that shared properties of both T and NK cells, were necessary for oral antibiotics amelioration of murine EAE (). While it is unknown whether enteric microbiota affect human MS, a higher percentage of MS patients exhibited antibody responses against gastrointestinal antigens in contrast to healthy control, which could indicate altered gut microbiome and immune status(). Oral treatment with a single bacterium or bacteria mixture can modulate EAE as observed in a range of studies. Probiotic Bifidobacterium animalis reduced the duration of symptoms in a rat EAE model(). Conversely, probiotic strain Lactobacillus casei Shirota (LcS) exacerbated EAE symptoms in rats(). However, later studies indicated that probiotic Lactobacilli, inclusive of LcS, did not enhance but rather suppressed rat EAE(). This has been corroborated by other studies using probiotic mixtures of strains under the Lactobacillus genus. Indeed, Lactobacilli (including LcS), either administrated alone or in combination with other strains of Bifidobacterium genus, tend to alleviate murine EAE symptoms via reciprocal regulation of pro- and anti-inflammatory cytokine responses(; ; ; ). Probiotic treatment with B. fragilis and Pediococcus acidilactici (strain R037) also significantly reduced mice susceptibility to EAE(; ). In the case of the human commensal B. fragilis, capsular PSA expression was critical for its immune-regulatory functions(). Further, engineered strains such as Salmonella-CFA/I and Hsp65-producing Lactococcus lactis can prevent EAE in mice via Tregs-associated TGFβ and IL-13 signals(; ; ). Isolated commensal microbial products can often recapitulate the biological effects of their parent organisms on hosts. Some of these products have been found as potent therapeutics against EAE. Purified B. fragilis PSA, referred to as a symbiosis factor in other studies, conferred prophylactic as well as therapeutic protection against EAE via induction of tolerogenic CD103+DCs at CNS-draining lymph nodes, similar to the effects conferred by probiotic B. fragilis(). While PSA is a TLR2 ligand, its immune-regulatory functions against EAE are not seen as putative in other commensal-derived TLR2 ligands. Nichols, et al. reported that a unique lipid TLR2 ligand, phosphorylated dihydroceramide (PE DHC), derived from human oral commensal Porphyromonas gingivalis but also gut commensals, was able to exacerbate murine EAE via TLR2-dependent mechanisms(). Commensal-derived extracellular ATP can be viewed as a danger-associated molecular pattern (DAMP) by hosts and has been related to Th17 development. Accordingly, Entpd7-/- mice that are deficient of ATP hydrolyzing enzymes have displayed a more severe level of EAE(). Finally, diet patterns have been reported to influence the development of EAE. Piccio et al. found that high-fat diet increased murine EAE severity. In contrast, calorie restriction diet attenuated EAE symptoms, which was associated with hormonal, metabolic and cytokine changes rather than immune suppression(). Kleinewietfeld et al. illustrated that mice fed with a high-salt diet developed a more severe form of EAE, in line with the ability of sodium chloride to activate Th17 cells(). Recent developments may insinuate a central role of gut microbiome in linking diet with MS and EAE. 3.1.2. Neuromyelitis opticaNeuromyelitis optica (NMO), also known as Devic's disease, is a CNS autoimmune disease featured by immune-mediated demyelination of the optic nerve and spinal cord. It resembles multiple aspects of MS. Auto-reactive humoral and T cell-mediated immunity against aquaporin 4 (AQP4), a predominant CNS water channel protein, drives the NMO pathogenesis(; ). Like MS, no research so far has established a direct link between gut microbiome and NMO. Banati et al. found that patients of AQP4-seropositive NMO and NMO spectrum diseases showed much higher serum level of antibodies against gastrointestinal antigens (most frequently dietary proteins) than did healthy controls, insinuating the alteration of microbiota composition and consequent immune status in NMO patients(). Varrin-Doyer et al. found that AQP4-specific T-cells in NMO patients showed cross-reactivity to a protein of the indigenous gut commensal species, Clostridium perfringens, supporting a microbiota-related molecular mimicry process in NMO pathogenesis(). 3.1.3. Guillain–Barré syndromeGuillain–Barré syndrome (GBS) is an autoimmune disease of the peripheral nervous system. Similar to MS, auto-reactive immune attack of myelin acts as the cause of neuro-degeneration in GBS(). Preceding infection with bacteria or virus, such as Haemophilus pneumoniae, Mycoplasma pneumoniae, influenza, and EBV, has been suggested as environmental triggers for GBS. Indeed, cross-reaction of pathogen-induced antibodies against neural surface antigens in a molecular mimicry process constitutes an important mechanism for GBS neuronal damage that leads to acute flaccid paralysis(). Campylobacter jejuni, a gut commensal species found in poultry, is a major cause of human enteritis induced by food contamination. Tam et al. indicated a far greater risk of GBS among Campylobacter enteritis patients than previously reported by retrospective serological studies(). Further, Campylobacter is associated with several pathologic forms of GBS. Different strains of Campylobacter, along with host factors, play an important role in shaping auto-reactive immune reactions during GBS development(). Therefore, C. jejuni represents a gut-associated pathogen that mediates neural autoimmunity. 3.1.4. Other immune-mediated conditionsThe role of microbiome has been implicated in other immune-involved CNS diseases. Meningitis is inflammation of the protective membranes of the CNS. Viral or bacterial infection may lead to meningitis. Zelmer et al. reported that the adult gut commensal Escherichia coli K1 were able to cause meningitis via maternal transfer to newborn infants. The polysialic acid (polySia) capsule synthesized by E. coli K1 guided the critical process of blood-to-brain transit of this neuro-pathogenic strain(). Chronic fatigue syndrome (CFS), also referred to as myalgic encephalomyelitis (ME), is so far of unknown etiology. Immune factors, such as chronic lymphocyte over-activation and cytokine abnormalities, contribute to its pathogenesis(). Maes et al found that increased IgA responses to commensal bacteria in CFS patients were associated with inflammation, cellular immune activation, and symptomatic severity. It was postulated that elevated translocation of commensal bacteria could be responsible for the disease activities in some CFS patients(). 3.2. How microbiome affects non-immune-mediated CNS disorders3.2.1. Autism and depressionAutism spectrum disorder (ASD) is a range of developmental neuro-behavioral disorders characterized by impaired social interaction and communication. Autism represents the primary type of ASD. Emerging data have indicated a link between gut microbiome and ASD, either as direct causality or as indirect consequences of atypical patterns of feeding and nutrition(). Disruption of gut microbiota might promote the over-colonization of neurotoxin-producing bacteria and thus contribute to autistic symptoms. It has been reported, however, that oral vancomycin treatment brings short-term benefit to regressive-onset autism children(). General gut microbiota alteration or specific gut commensal strains have been implicated in ASD. Bolte et al. postulated that Clostridium tetani could induce autism(). Indeed, two ensuing human gut microbiome studies illustrated a greater number of species under the Clostridium genus present in fecal samples of autistic children(; ). An imbalance of Bacteroidetes and Firmicutes phyla also manifests in autistic children. Finegold et al. reported increased presence of Bacteroidetes in severe autistic group and predominant presence of Firmicutes in healthy controls(). Williams et al. revealed a reverse trend in comparing autism and GI disease co-morbid (AUT-GI) children and GI disease alone controls(). In addition, altered levels of other gut commensals, including those of Bifidobacterium, Lactobacillus, Sutterella, Prevotella and Ruminococcus genera and of the Alcaligenaceae family, were correlated with autism(; ; ; ). Nonetheless, there are studies refuting the microbiota alteration between autistic and healthy subjects(). Variance in sampling strategies and techniques applied to microbiome assays may account for these differences. Further, gut microbiome-mediated metabolism also impacts autism. Metabolites profile gathered from both urinary and fecal samples differed in autistic patients and healthy control, potentially consequent of microbiota changes(; ; ). Depression is a major form of mood disorder that results from neuro-psychiatric disturbance or immunological deregulation(). Probiotic treatment has shown efficacy in suppression of animal depression models. Species under Lactobacillus genus are particularly characterized as anti-depressant. Probiotic mixture comprising L. rhamnosus and L. helveticus strains ameliorated maternal separation-induced depression via normalizing corticosterone level(). Similarly, L. rhamnosus strain JB-1 reduced depression-related behavior through regulating corticosterone and GABA receptor in a vagal-dependent manner(). Species of Bifidobacterium are also potent anti-depressants. Bifidobacterium infantis alleviated depression as indicated by rat forced swim test (FST) and maternal separation models. Mechanisms involved include attenuation of pro-inflammatory cytokines, regulation of tryptophan metabolism and CNS neurotransmitters(; ). Probiotics combining Lactobacilli and Bifidobacteria were tested in post-myocardial infarction depression models. L. helveticus and Bifidobacterium longum together ameliorated post-MI depression through reduction of pro-inflammatory cytokines and restoration of barrier integrity at GI tract(; ). In addition, gut microbial products, such as sodium butyrate (salt formed from butyrate acid, a type of SCFA) have been explored in animal depression model, without showing anti-depressant effects(). Further, a diet formulation containing high levels of polyunsaturated fatty acids (PUFAs) n-3 attenuated rat post-MI depression via similar mechanisms as did L. helveticus and B. longum(). 3.2.2. Anxiety and stressAnxiety and stress are common forms of mood disorders with nervous, endocrinal and immunological basis. Exposure to stressors such as chemical, biological or environmental stimuli can trigger stress and anxiety responses, which involves activation of the HPA axis. As aforementioned, co-morbidity with anxiety and stress has been perceived in drastic and mild types of intestinal dysfunctions, underscoring the role of gut-brain signals such as neurotransmitters and immune factors(; ; ; ; ; ). GF mice showed increased motor activity and reduced anxiety, compared to SPF mice with normal gut microbiota. This behavioral phenotype was associated with higher levels of neurotransmitters and reduced synaptic long-term potentiation in the CNS of GF mice(). Reduced anxiety-like behavior in GF condition has been confirmed by later studies, which are explained by other neurochemical changes such as decreased neurotransmitter receptors and increased tryptophan metabolism. It is therefore postulated that gut microbiome regulates the set point for HPA axis(; ). Gut-associated pathogens can exacerbate anxiety. Infection with C. jejuni elevated anxiety-like behavior through induction of the c-Fos protein, a neuronal activation marker, in the CNS as well as ANS(; ). C-Fos protein induction was also indicated in Citrobacter rodentium exacerbation of anxiety, whereas Trichuris muris elevated anxiety via immunological and metabolic mechanisms(; ). In contrast, beneficial probiotics can ameliorate anxiety. Specific species of Lactobacillus and Bifidobacterium genera have anxiolytic effects. Probiotic treatment with certain strains of B. longum, B. infantis, L. helveticus, or L. rhamnosus, either alone or in combination, normalized behavioral phenotypes in animal anxiety models(; ; ; ; ). Programming of HPA axis by gut microbiome is also observed in stress condition. GF mice showed exaggerated HPA stress response, accompanied by increased circulatory neurotransmitters and decreased brain-derived neurotrophic factor (BDNF) expression in the CNS(). Altered gut microbiota composition has been associated with stress. O'Mahony, et al. reported changes in fecal microbiota in early life stress induced by maternal separation(). Murine exposure to the SDR stressor led to decreased abundance of Bacteroides, increased abundance of Clostridium, and changes of other bacteria genera, which were concurrent with enhanced circulatory pro-inflammatory cytokines(). The anxiolytic strains of Lactobacillus and Bifidobacterium genera that have anti-anxiety effects often display anti-stress effects as well. Ingestion with L. helveticus and L. rhamnosus reduced rat chronic psychological stress indicated by water avoidance test and improved intestinal barrier integrity(). Lactobacillus farciminis also suppressed stress-induced gut leakiness and attenuated HPA axis stress response(). B. longum normalized anxiety-like behavior and CNS BDNF levels in mice co-morbid with infectious colitis through a vagal-dependent mechanism(). A probiotic formulation consisting of L. helveticus and B. longum showed anxiolytic-like activities in rats and beneficial psychological effects in healthy human subjects(). 3.2.3. PainNociceptive pain that is caused by peripheral nervous response to stimuli and signaling transduction to the CNS can be alleviated by probiotic modulation of microbiome. Antinociceptive effects are seen in species of Lactobacillus genus. L. farciminis ameliorated stress-induced hypersensitivity to colorectal distension (CRD), mediated by inhibition of colonic epithelial contraction and nitric oxide (NO)-related mechanisms(). L. reuteri also attenuated visceral pain induced by CRD in normal rats(). L. paracasei normalized visceral hypersensitivity to CRD in antibiotics-perturbed mice (). Lactobacillus acidophilus delivered analgesic effects in intestinal pain via induction of opioid and cannabinoid receptors(). Besides, two studies supported the anti-nociceptive effects of a specific B. infantis strain in the context of IBS. Probiotic B. infantis reduced CRD-induced pain in both visceral normal-sensitive and visceral hypersensitive rat strains, and also in a rat model of post-inflammatory colonic hypersensitivity(; ). Recently, Chiu et al. reported that S. aureus triggered pain in mice through direct induction of calcium flux and action potentials in nociceptor neurons(). 3.2.4. Other neuro-psychiatric symptomsMicrobiome has been connected with other neuro-psychiatric disorders, where a mixture of immune- and non-immune-based etiologies often occurs. GF animals exhibit defective memory and cognitive abilities. Gareau et al. found that memory dysfunction occurred in GF mice regardless of exposure to stress(). Bercik et al. showed that re-colonization of GF mice with murine microbiota could either enhance or reduce exploratory behavior, depending on the strains of donor and recipient mice. Further, antibiotic treatment of SPF mice increased exploratory behaviors. Hippocampal levels of BDNF were positively correlated with exploratory behaviors, and regulated in both cases(). Probiotics were able to improve infection-induced memory dysfunction and diabetes-induced cognitive defects(; ). Propionic acid, a type of SCFA, reduced murine social and cognitive abilities(). Dietary alteration of gut microbiome also modulated murine cognitive and learning behaviors(). Microbiota alteration has been indicated in hepatic encephalopathy (HE). Different fecal and mucosal microbiota were found in HE patients as compared to healthy controls. In cirrhotic HE specifically, good cognition and decreased inflammation were linked with autochthonous and Prevotella genera as well as Alcaligenaceae and Porphyromonadaceae families, whereas poor cognition and increased inflammation were linked with over-represented Enterococcus, Megasphaera and Burkholderia genera(; ; ). Alteration of serum antibodies to oral microbiota and sub-gingival bacterial species was observed in Down's syndrome(; ). Oral microbiota changes were also observed in comatose patients(). A positive correlation between schizophrenia and serological surrogate markers of bacterial translocation was indicated(). 4. Factors linking microbiome and the CNSAs microbiome refers to the collective genomes of total microbiota, microbiome research is broad in its scope, which incorporates general microbiota composition or specific bacterium, microbiota-generated products, external alteration of microbiota, and barrier integrity status that affects host-microbiota contact. It is thus worthy summarizing the factors that mediate the influence of microbiome on CNS disorders. 4.1. HygieneThe hygiene hypothesis states that a lack of childhood exposure to infectious agents, parasites and commensals increases susceptibility to T helper 2 (Th2)-mediated allergic diseases. However, there also exists a correlation between improved sanitary conditions and increased incidences of T helper 1 (Th1)-mediated autoimmune diseases such as T1 diabetes and multiple sclerosis(). Th1 response targets intracellular microbes, mediated by signature cytokine IFNγ; while Th2 response targets helminthes and allergens, characterized by signature cytokines IL-4 and IL-13. Aberrant immune development is therefore a potential mechanism that links hygiene and immune-mediated CNS disorders. GF mice displayed reduced EAE symptoms, concurrent with attenuated Th1, Th17 and B cell responses, which related to the hygiene hypothesis yet contradicted findings in human MS(; ). This discrepancy might be explained by intricate etiologies underlying human MS and intrinsic differences between murine GF condition and human hygienic state. In murine models, GF condition is also linked to neuro-behavioral disorders. Total sterility results in reduction of BDNF levels and enhancement of HPA axis responses, correlated by elevated neurotransmitters in the plasma. GF animals displayed increased stress and impaired cognition(; ). However, GF condition in other studies is identified as anxiolytic and can resolve anxiety, correlated by decreased neurotransmitter receptors levels(; ). Hence, hygiene exerts case-specific rather than universal influences on neuro-chemistry and neuro-behavioral manifestations. 4.2. Antibiotics usageAntibiotics confer selective alteration of gut microbiota. Mice pre-conditioned with oral antibiotics are less susceptible to autoimmune models such as EAE. In studies conducted by Ochoa-Reparaz et al., amelioration of EAE was associated with reduced IFNγ and IL-17, increased IL-13 and IL-10, and systemic stimulation of Tregs and Bregs(; ). That antibiotics poise the Th1/Th2 equilibrium towards Th2 direction is consistent with hygiene hypothesis. An earlier study conducted by Yokote et al. also observed reduced pro-inflammatory cytokines, including IFNγ and IL-17, in antibiotic treatment of EAE. While iNKT cells were not induced by antibiotics, they were essential for protection against EAE(). Different antibiotic agents were utilized in these EAE studies, which could result in different gut microbiome profiles and explain the variability of immune mechanisms. Current studies support a beneficial role of antibiotic treatment of neuro-behavioral disorders. Antibiotic treatment reduced stress response and increased exploratory behavior in mice and offered short-term benefit to regressive-onset autism children. Underlying mechanisms may involve the reduction of luminal LPS concentration (and thus potentially reduced chronic inflammation) and changes of CNS signals, such as hippocampal expression of BDNF(; ; ). In sum, antibiotics might reset the default immune and neuro-hormonal status shaped by commensal microbiome and therefore alter predisposition to CNS disorders. 4.3. Microbiota compositionHow microbiota composition impacts CNS disorders can be indicated by a variety of methodologies, including infection-induced microbiome perturbation, studies using SPF and gnotobiotic mice, mono-colonization of GF mice, and metagenomic approaches such as microbial microarray and 16S rRNA profiling. Further, compositional changes of microbiota can be indirectly reflected by profiling the metabolites and co-metabolites of microbiota and serum titers of antibodies against microbiota and diet components. As the study of enterotypes is still in its infancy, efforts to find disease-specific enterotypes are limited. Hildebrand et al. defined two murine enterotypes, ET1 and ET2 that bore striking similarity to Ruminococcus and Bacteroides enterotype in human, respectively. ET2 mice showed higher levels of fecal calprotectin, a biochemical marker for IBD(). For CNS disorders, a concrete link with enterotypes has yet to be established. While it is tempting to infer enterotypes from the scattered studies of certain disease type, opposing data often obstruct consensus. For instance, there are favorable and unfavorable results for the link between Bacteroides enterotype and autism(; ). Further, heed must be taken to clarify the cause and effect as CNS disorders could impact diet patterns or be concurrent with gut epithelial impairment, both scenarios affecting microbiota composition. 4.4. ProbioticsIngestion of beneficial live bacteria, also know as probiotics, is a therapeutic way of using microbiota components for treatment. Probiotics can regulate immune subsets, especially in the case of CNS autoimmunity. B. fragilis is a prominent probiotic strain that promotes Foxp3+Treg quantity and functional maturation in both EAE and IBD(; ). Lactobacilli and Bifidobacteria are key components of anti-inflammatory probiotic mixtures that can also function through stimulation of IL-10+Foxp3+Tregs(; ). Moreover, genetic modification of natural strains represents another potent probiotic approach. Fusing tolerogenic antigen into attenuated or innocuous strains has yielded oral therapeutics against EAE(; ; ). Probiotics can alleviate neuro-psychiatric disorders via hormonal and neuro-chemical mechanisms. For example, B. longum NCC3001 can normalize murine hippocampal BDNF expression and L. rhamnosus (JB-1) can exert differential regulation of GABA transcription in different CNS regions(; ). Particular probiotics may convey anxiolytic effects in multiple types of neuro-behavioral disorders, which indicates shared neural and endocrinal etiologies of these disorders. For example, L. helveticus R0052 and B. longum R0175 can ameliorate both anxiety and depression in rats(; ). Neural mechanisms that involve direct bacterial activation or inhibition of neurons may account for anti-nociceptive effects of probiotics. 4.5. Microbiota-derived productsMicrobiota-derived products are often effective components responsible for microbiota-gut-CNS signaling. This is especially evident in the case of B. fragilis capsular PSA, where PSA can recapitulate the functions of its parent organism B. fragilis in regard to anti-inflammatory effects in EAE and activation of intestinal sensory neurons. PSA is a unique zwitterion and referred to as a symbiosis factor for commensalism(; ). Commensal-produced luminal extracellular ATP and LPS drive the chronic inflammation that contributes to the pathogenesis of neuro-immune and neuro-psychiatric disorders. Microbiota-derived metabolites and co-metabolites are critical intermediaries for microbiota-gut-CNS signaling. Commensals spawn a range of neuro-active substances. For example, Lactobacillus and Bifidobacterium species can produce the inhibitory neurotransmitter GABA(). The involvement of neuro-active metabolites in probiotic effects on neuro-psychiatric disorders remains unexplored. SCFAs, a group of fatty acids with aliphatic tails of 2 to 6 carbons, are fermentation products of dietary fibers by microbiota. While SCFAs have been found to be important immune regulators, there is a scarcity of studies that target at their impacts on CNS disorders(; ). 4.6. DietDiet patterns may modulate gut microbiome via alteration of nutrient availability. Recent developments have suggested that dietary intervention can impact gut microbial gene richness. Download game of thrones s6e6. Lower microbiome richness was identified as less healthy and associated with metabolic dysfunction and low-grade inflammation. Dietary formula with higher fiber contents can improve microbiome richness(; ). Unhealthy diet patterns containing high levels of fat or salt could accelerate neuro-inflammation during EAE(; ). Western-style diet could negatively affect anxiety-like behavior and memory, depending on immune status(). Supplementation with high levels of PUPAs could alleviate depression(). These experimental findings could indicate saturated fat as a risk factor for both neuro-immune and neuro-psychiatric disorders. Collectively, microbiome modulation is an integral mechanism underlying diet-based treatment. 4.7. Gut permeabilityGut permeability has been directly and indirectly associated with the role of microbiome in CNS disorders. Humoral and cellular immune reaction to microbiota in the circulation, persistent low-grade inflammation and neuro-psychiatric co-morbidity with IBD may hint the breach of mucosal epithelial barrier(; ; ; ; ; ). Probiotic treatment with several species of Lactobacillus genus restored the barrier integrity(; ). Dysbiosis and breakdown of mucosal barrier are interrelated phenomena. Microbiota and their ligands maintain the cell-cell junctions critical to barrier integrity(; ). Abnormal gut microbial composition is seen in IBD(). In return, the cascade of inflammatory process during IBD may amplify intestinal dysbiosis. Although it is hard to determine the initial cause, dysbiosis and gut hyper-permeability orchestrate in driving CNS pathogenesis. 5. Conclusions and perspectivesAccumulating information of animal and human research strengthen the concept of microbiome-gut-brain axis. Microbiome controls canonical aspects of the CNS, immunity and behavior in health and disease. Still, unknowns abound regarding the detailed role of microbiome in CNS disorders. First, the relative contributions of immune, neural, and endocrine pathways in microbiome-CNS communications at pathological states need to be clarified. Second, it is crucial to elucidate the factors at play in microbiome-based therapeutics and further refine the effective components. Third, caution should be applied to the translation of animal data to human clinics using existing microbiome studies. Microbiome research holds conceivable promise for the CNS disorder-relevant prognosis and therapeutics. Correlational studies that associate microbiota compositional patterns with specific disorders such as autism types contain prognostic value. Multitudes of commensal bacteria co-exist with hosts without incurring harmful immune responses. Symbiotic strains and their products are thus a precious mining pool that contains useful drug candidates with host-tolerated immune-modulatory functions. Innocuous commensal strains could also act as carriers for therapeutic substances when engineered. Finally, to restore the richness and functionality of gut microbial ecosystem by fecal transplantation has been proposed long time ago yet methodological and ethical obstacles remain. Microbiome-gut-brain axis in relation to CNS disordersMultiple pathways guide the downward and upward directions of the microbiome-gut-brain axis in the contexts of health and disease. (A) Downwardly, CNS controls gut microbiome composition through satiation signaling peptides that affect nutrient availability, endocrines that affect gut functions and neural pathways. HPA axis release of cortisol regulates gut movement and integrity. Immune (cells, cytokines and sIgAs) pathways can be turned on in response to altered gut functions. Endocrine and neural pathways can also regulate the secretion from specialized gut epithelial cells, including paneth cells, enteroendocrine cells (ECC) and goblet cells. Their secretory products affect the survival and resident environment of microbiota. (B) Upwardly, gut microbiome controls CNS activities through neural (direct activation of neurons by microbiome), endocrine (e.g. ECC release of 5-HT), metabolic (microbiota synthesis of neuroactive molecules), and immune (CNS infiltrating immune cells and systemic inflammation) pathways. Microbiome influences CNS at healthy (neuro-development) and disease (a range of neuro-immune and neuro-psychiatric disorders) states. Gut luminal microbiota, their products sampled by APCs and epithelium-attaching SFBs mediate peripheral immune education. Gut microbiome composition, specific strains within microbiota, probiotic treatment, microbiota-derived products and other factors constitute the scope of microbiome studies. AcknowledgmentsWe thank Dr. Pamela Bagley (Dartmouth College) for literature assistance. Abbreviations
FootnotesPublisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. References
World J Gastroenterol. 2002 Jun 15; 8(3): 540–545.
Published online 2002 Jun 15. doi: 10.3748/wjg.v8.i3.540
PMID: 12046088
This article has been cited by other articles in PMC.
AbstractAIM: To determine whether Salmonella Typhimurium (STM) in gastrointestinal tract can induce the functional activation of brain, whether the vagus nerve involves in signaling immune information from gastrointestinal tract to brain and how it influences the immune function under natural infection condition. METHODS: Animal model of gastrointestinal tract infection in the rat was established by an intubation of Salmonella Typhimurium (STM) into stomach to mimic the condition of natural bacteria infection. Subdiagphragmatic vagotomy was performed in some of the animals 28 days before infection. The changes of Fos expression visualized with immunohistochemistry technique in hypothalamic paraventricular nucleus (PVN) and superaoptic nucleus (SON) were counted. Meanwhile, the percentage and the Mean Intensities of Fluorescent (MIFs) of CD4+ and CD8+ T cells in peripheral blood were measured by using flow cytometry (FCM), and the pathological changes in ileum and mesenteric lymph node were observed in HE stained sections. RESULTS: In bacteria-stimulated groups, inflammatory pathological changes were seen in ileum and mesenteric lymph node. The percentages of CD4+ T cells in peripheral blood were decreased from 42% ± 4.5% to 34% ± 4.9% (P < 0.05) and MIFs of CD8+ T cells were also decreased from 2.9 ± 0.39 to 2.1 ± 0.36 (P < 0.05) with STM stimulation. All of them proved that our STM-infection model was reliable. Fos immunoreactive (Fos-ir) cells in PVN and SON increased significantly with STM stimulation, from 189 ± 41 to 467 ± 62 (P < 0.05) and from 64 ± 21 to 282 ± 47 (P < 0.05) individually, which suggested that STM in gastrointestinal tract induced the functional activation of brain. Subdiagphragmatic vagotomy attenuated Fos expression in PVN and SON induced by STM, from 467 ± 62 to 226 ± 45 (P < 0.05) and from 282 ± 47 to 71 ± 19 (P < 0.05) individually, and restored the decreased percentages of CD4+ T cells induced by STM from 34% ± 4.9% to original level 44% ± 6.0% (P < 0.05). In addition, subdiagphragmatic vagotomy itself also decreased the percentages of CD8+ T cells (from 28% ± 3.0% to 21% ± 5.9%, P < 0.05) and MIFs of CD4+ (from 6.6 ± 0.6 to 4.9 ± 1.0, P < 0.05) and CD8+ T cells (from 2.9 ± 0.39 to1.4 ± 0.34, P < 0.05). Both of them manifested the important role of vagus nerve in transmitting immune information from gut to brain and maintaining the immune balance of the organism. CONCLUSION: Vagus nerve does involve in transmitting abdominal immune information into the brain in STM infection condition and play an important role in maintenance of the immune balance of the organism. INTRODUCTIONIt has been suggested in recent studies that the vagus nerve, the tenth cranial nerve, might play an important role in transmitting immune information into the brain[-5]. However, this conclusion is based on the experiments in which cytokines, endotoxins or exotoxins were usually used as immune stimulators through intraperitoneal or intravenous injection. All these immune stimulations, however, are non-natural and the role of vagus in natural infection condition has not been established yet. Salmonella Typhimurium (STM) belongs to the group B of Salmonella. It can infect both human beings and animals through gastrointestinal tract and leads to a local or general infection by inhibiting the host immune system[]. Thus, in the current experiments we introduced Salmonella Typhimurium (STM) into stomach to mimic the natural bacteria infection in gastrointestinal tract and to reassess the role of vagus in transmission of immune signal by subdiagphragmatic vagotomy. The production of c-fos, an immediately early gene, has been used as a morphological marker of functionally activated brain neurons[-]. In the present study we observed the STM-induced Fos expression in hypothalamic paraventricular nucleus (PVN) and superaoptic nucleus (SON) and the effect of vagotomy. We also studied the importance of integrity of vagus nerve in the balance of T cell subpopulations. MATERIALS AND METHODSAnimalsAdult male Sprague Dawley albino rats (180-210 g, offered by Animal Center, Fourth Medical University) were used. Rats were housed individually in a temperature-controlled room in a natural light/dark cycle, with food and water available freely. The animals were trained for adaptation to handling and gastric intubation before the following procedures started. Vagus Nerve Visceral Ep Download Torrent 1ProceduresSubdiagphragmatic vagotomy Rats were anesthetized with pentobarbital sodium (40 mg/kg, i.p.) and subjected to a complete subdiagphragmatic vagotomy (n = 10) or sham operation (n = 10). Briefly, after laparotomy, the two trunks of vagus were identified under an operating microscope. Both trunks were cut off close to the diaphragm. For sham vagotomy, the vagus was similarly exposed but was not cut. After surgery, a recovery period of 28 days was allowed. Preparation of STM Wild strain of STM (offered by Laboratory of Bacteria, Xijing Hospital, Fourth Medical University) was preserved in freeze-dried powder before use. In order to enhance the pathogenicity of the bacteria, STM were sub-cultured in mice abdomen (Kunming mice offered by Animal Center, Fourth Medical University) for 3 times and then the number of the bacteria was adjusted to 1010/mL for use. Intubation of STM Rats (n = 20) were divided into 4 groups randomly, 5 for each. Group 1, saline (NS) + sham operation; 2, NS + vagotomy; 3, STM + sham operation; 4, STM + vagotomy. Food was taken away from the rats 24 h prior to intubating STM or saline. After anesthetized with ether, all rats were intubated with 30 g/L NaHCO3 300 μl to neutralize gastric acid. Then the aminals of groups 3 and 4 were gastrically intubated with STM (1010 in saline, 1 mL) and in the others (Groups 1 and 2) 1 mL of saline were given. Perfusion and Sectioning After intubation for 22 h, all rats were deeply anesthetized with pentobarbital (80 mg/kg) and 1 mL of blood was taken via heart as quickly as possible. The rats were then perfused transcardially with saline 100 mL followed by 4% paraformaldehyde in 0.1M phosphate buffer (PB) 500 mL, pH7.4, at 4 °C. Blood was anti-coagulated with heparin. Brains, part of ileum and mesenteric lymph node were taken out and cryoprotected in 20% sucrose in 0.1 M PB overnight at 4 °C. Frontal sections in 50 μm-thickness were cut through whole brains with a microtome and collected in cold cryoprotectant and stored at -20 °C until immunohistochemistry processing. Serial ileum and mesenteric lymph node sections in 5 μm-thickness were cut with a cyostat and mounted onto slides coated with gelatin and stored at -20 °C until histochemistry processing. HE staining of ileum and mesenteric lymph node sections Slides of ileum and mesenteric lymph node were immersed successively in dimethylbenzene (10 min × 2), graded ethanol (100% 5 min × 2, 95% 2 min, 80% 2 min, 70% 2 min and distilled water 2 min), Harris hematoxylin (5-10 min) and 10% acid ethanol for several seconds. After rinsed with tap water for 30 min, slides were immersed again successively in distilled water (10-30 min), graded ethanol (70%, 80%, and 95% 2 min for each), 0.5% eosin (5-10 min), 95% ethanol from several seconds to minutes, 100% ethanol (5 min × 2) and dimethylbenzene (10 min × 2). At last, the slides were sealed with gum and observed under a light microscope (Olympus B × 60). Flow cytometry (FCM) of blood T Cell Blood CD4+ and CD8+ Tlymphocytes were labeled by using indirect immunofluorecent labeling method. First, 80 μl of anti-coagulated blood was incubated with mice anti rat CD4 mAb (1:100, Serotec company) or 15 μl of mice anti rat CD8 mAb (1:100, Serotec company) for 30 min at 4 °C, then with 40 μl of goat anti mice IgG-FITC (1:100, Serotec company) after washing twice with 0.01Mol/L Phosphate-buffered saline (PBS). FCM was used to detect the percentages and the Mean Intensities of Fluorescence (MIFs) of CD4+ and CD8+ T cells. Immunohistochemistry of Brain Sections ABC immunohisto chemical technique was used to detecte Fos-immunoreactive (Fos-ir) cells in brain. One-in-five of brain sections were incubated with primary antibody raised from rabbit against Fos protein (Sigma Inc.) at a dilution of 1:3000. After incubation at room temperature for 36 h, sections were rinsed with 0.01Mol/L Phosphate-buffered saline (PBS) (10 min × 3) and then incubated with biotinylated secondary antibody against rabbit IgG (Sigma Inc, diluted at 1:500) at room temperature for 4 h. After rinsing with 0.01Mol/L PBS (10 min × 3), sections were incubated with avidin-biotin-horseradish peroxidase (1:500, Sigma Inc.) at room temperature for 2 h. The reaction product was visualized with amine nickel sulfate-enhanced 3,3’-diaminobenzidine (DAB) method. The sections were dehytrated in graded ethanol, cleared with dimethylbenzene, and coverslipped with gum. Counting of Fos-ir cells Sections of hypothalamus were observed with a light microscope (Olympus BX60). The number of Fos-ir cells was quantified by counting immunostained nuclei in PVN or SON at two consecutive typical sections with an image analysis system (Leica Quantimet 570 C). The number of Fos-positive nuclei in PVN or SON was the group mean ± SE. Statistical analyses All data were expressed as mean ± SE and were analyzed by one-way ANOVA. Post hoc analysis was done by using the Student-Newman-Keuls (SNK) multiple comparison test. A value of P < 0.05 was considered significant. RESULTSHE stainingInflammation change was seen in ileum and mesenteric lymph node in the rats stimulated with STM. There are numerous bacilli in ileum cavity in the infected rats. The structure of the villus of the infected ileum was destroyed (Figure (Figure1,1, E2), part of epithelial cells were scaled, and many neutrophil, red blood cell and fibroblast infiltrated into the villus. At the same time, secondary lymphoid folliculi appeared in mesenteric lymph node (Figure (Figure1,1, E4). Figure Figure1,1, E1 and E3 show the normal tissue image of the villus and mesenteric lymph node in saline-treated rat. In Figures E1 and E3 show the normal structures of the villus and mesenteric lymph node in saline-injected rats; 2 and 4 show the villus and mesenteric lymph node in STM-challenged rats. 5 and 9 show Fos expression in PVN and SON respectively in NS + sham rats; 6 and 10 show Fos expressions in PVN and SON respectively in STM + sham rat; 7 and 11 show Fos expressions in PVN and SON respectively in STM + vagotomy rat; 8 and 12 show Fos expressions in PVN and SON respectively in NS + vagotomy rat. × 50 FCMTable Table11 shows the percentages and MIFs of CD4+and CD8+ T cells in every group. Table 1Percentages (%) and MIF of CD8+ and CD4+ T cells (-x ± s)
bP < 0.05 vs NS + sham
Figure Figure2A2A shows that subdiagphragmatic vagotomy itself in normal animals had no evident effect on the percentages of CD4+ T cells, but the stimulation of STM itself in sham-operated animals decreased the percentages of CD4+ T cells from 42% ± 4.5% to 34% ± 4.9% (P < 0.05) and after subdiagphragmatic vagotomy the decreased percentages of CD4+ T cells in STM stimulated rats restored from 34% ± 4.9% to 44% ± 6.0%, the level of non-STM stimulated rats (P < 0.05). A: Percentages of blood CD4+ T cells. aP < 0.05 vs. STM + sham, bP < 0.05 vs NS + sham; B: The Mean Intensities of Fluorescence (MIFs) of blood CD4+ T cells. bP < 0.05 vs NS + sham; C: Percentages of blood CD8+ T cells. aP < 0.05 vs STM + sham, bP < 0.05 vs NS + sham; D: The Mean Intensities of Fluorescence (MIFs) of blood CD8+ T cells. aP < 0.05 vs STM + sham; bP < 0.05 vs NS + sham. Figure Figure2B2B shows that subdiagphragmatic vagotomy itself in NS+operation animals decreased MIFs of CD4+ T cells from 6.6 ± 0.6 to 4.9 ± 1.0 (P < 0.05), indicating the inhibition of subdiagphragmatic vagotomy to CD4+ T cells. Figure Figure2C2C and Figure Figure2D2D show that subdiagphragmatic vagotomy itself in normal rats decreased the percentages of CD8+ T cells (from 28% ± 3.0% to 21% ± 5.9%, P < 0.05) as well as MIFs of CD8+ T cells (from 2.9 ± 0.39 to 1.4 ± 0.34, P < 0.05). STM stimulation itself in sham-operated rats also depressed the percentages of CD8+ T cells (from 28% ± 3.0% to 21% ± 5.9%, P > 0.05) and MIFs of CD8+ T cells (from 2.9 ± 0.39 to 2.1 ± 0.36, P < 0.05). Subdiagphragmatic vagotomy in STM-challenged rats aggravated the inhibition of STM to the percentages of CD8+ T cells (from 23% ± 2.0% to 17% ± 5.8%, P < 0.05) and MIFs of CD8+ T cells (from 2.1 ± 0.36 to 1.1 ± 0.06, P < 0.05). ImmunohistochemistryTable Table22 shows the number of Fos-ir cells in PVN and SON in each group. The numbers of Fos-ir cells in PVN and SON of STM + sham-operated rats increased significantly compared with that of NS + sham from 189 ± 41 to 467 ± 62 (P < 0.05) and from 64 ± 21 to 282 ± 47 (P < 0.05) individually (Figure (Figure1,1, E5, E6, E9, E10). The positive neuron distributed in both magnocellular and parvocellular portions of PVN as well as dorsal and ventral parts of SON. Fos expressions were attenuated in PVN and SON in the rats of STM+vagotomy group compared with that of STM + sham group from 467 ± 62 to 226 ± 45 (P < 0.05) and from 282 ± 47 to 71 ± 19 (P < 0.05) individually (Figure (Figure1,1, E6, E7, E10, E11), but it was still higher than that of saline-treated animal (189 ± 41 and 64 ± 21 individually). There was no significant changes of Fos expression in NS + vagotomy rats compared with NS + sham rats (Figure (Figure1,1, E5, E8, E9, E12). Table 2
bP < 0.05 vs STM + sham
DISCUSSIONMore and more evidences have shown that there is a complicated bidirectional inter-relationship between nervous system and immune system[,-]. Immune signals produced during antigen challenge can be transmitted into central nervous system (CNS) and influence the function of the latter. In turn, CNS can modulate the activity of immune system. However, it is still an unsolved problem up to now how the immune signals are transmitted into CNS. Two of hypothesises have been proposed[-]: one is through humoral route and the other, via neural pathway. Among the neural pathways the vagus nerve in transferring peripheral immune signals into CNS has been paid more attention to[-5,,]. A large amount of evidences indicate that vagus plays an important role in surveying the peripheral immune information into CNS. For example, subdiagphragmatic vagotomy inhibits a series of brain-mediated responses to peripheral administration of lipopolysaccharide (LPS), IL-1β or TNF-β, such as induction of IL-1β mRNA within mice brain[,], activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion[,], LPS-induced fever in guinea pigs[], Fos immunoreactivity in primary afferent neurons of the vagus[], the inhibition of social exploration[], a monophasic fever[], the hyperalgesia[,] etc. Administration of IL-1β in hepatic portal vein induced afferent discharges of hepatic branch of vagus, but the discharges disappeared in vagotomy rats[]. Nucleus tractus solitarius lesions attenuated the first fever peak induced by intraperitoneal injection of IL-1β[].All of the above mentioned experiments indicate that intact vagus is necessary for transmitting the immune information from periphery, especially from peritoneal cavity, to the brain. According to the anatomical structure of vagus, the abdominal organs such as liver, stomach, intestines, lymph node, etc. are innervated mostly by subdiagphragmatic vagus and the vagus contains important visceral sensory afferent fibers from abdominal organs[,39]. Thus, we conjecture that subdiagphragmatic vagus may play an important role in transmitting the abdominal immune information into the brain and is important in maintaining immune balance. All the immune challenges used in previous studies were bacterial toxins such as LPS or immune cytokines injected intraperitoneally or intravenously. In this experiment we established a rat model of gastrointestinal tract infection by STM intubation to mimic the natural infection and a subdiagphragmatic vagotomy was performed to further observe the role of vagus in immune signal transmission. According to aetiology, STM can invade intestinal mucosa and largely reproduce, and then further spread into the drained mesenteric lymph nodes and disseminate via the bloodstream[]. STM is an intracellular Gram-negtive bacterial pathogen that infects both phagocytic and non-phagocytic cells[,-]. It can inhibit the host immune system and cause a range of diseases including enteric fever and gastroenteritis[]. It has been reported that the depletion of either CD4+ or CD8+ T cells by STM impairs their ability to transfer protective immunity to virulent S. typhimurium[]. These studies indicate that CD4+ and CD8+ T cells act synergistically to control infection with virulent S. typhimurium[,,]. In our experiment the villus of the infected ileum was destroyed, part of epithelial cells scaled, and the number of neutrophils, red blood cells as well as fibroblasts increased in the villus. At the same time, secondary lymphoid folliculus stimulated with STM emerged in mesenteric lymph nodes. The percentages of CD4+ and CD8+ T cells and MIFs of CD8+ T cells of peripheral blood were all inhibited, which was consistent with the previous reports. These changes induced by STM suggest that our STM infection model was reliable. The result showed that in NS + sham rats Fos proteins expressed in a few of PVN and SON neurons, which suggests that in normal condition some PVN and SON neurons are active, and may is related to the modulation of routine metabolic activities. After being stimulated with STM the number of Fos-ir cells significantly increased in PVN and SON. It indicated that these cells were activated by STM-challenge. It is well known that CNS, especially hypothalamus, involves in modulation of acute immune reaction[]. PVN and SON, which are two most important nuclei in hypothalamus related to autonomic function, are mainly composed of three kinds of neurons neurochemically: oxytocinergic, vasopressinergic and CRH neurons[]. All of these three kinds of neurons can involve in neuroimmunomodulation[]. Yang et al[] reported that, as the neuroimmunomodulation integrating center, hypothalamic PVN modulates the immune function through three pathways: The first is CRH-ACTH-adrenal cortex axis, the second is oxytocin neuroendocrine pathway, and the third is PVN-spinal cord sympathetic preganglionic projection. Although we can’t determine which kind of neurons were activated in this experiment since we did not apply double-labeling technique to identify them, we proposed from the observation of distribution of Fos positive neurons in the subnuclei of PVN and SON that, maybe, all these three kind neurons were activated. But, how the immune signals are transmitted into the brain is an important and unsolved question. Is it through vagus or humoral pathway, or both of them? What we focused on in the present study was the role of vagus in the sensation and transmission of immune signals to brain. So, we severed subdiagphragmatic vagus to observe whether the Fos expressions in PVN and SON induced by STM infection and the T cell subpopulation were influenced. After subdiagphragmatic vagotomy, Fos expressions in PVN and SON were attenuated. At the same time we found that the decreased percentage of CD4+ T cells in STM-infected rats restored after subdiagphragmatic vagotomy. These results indicate the importance of intact subdiagphragmatic vagus in signaling immune information from abdominal organs to CNS. We tend to conclude from our results that subdiagphragmatic vagus does play a role in transferring immune information into brain during the abdominal inflammatory phase. Vagus Nerve Visceral Ep Download Torrent PcHowever, the detailed mechanism about how vagus nerve senses the immune stimulation and transfers it into electric signal is still not fully understood. It is known that macrophages, dendritic cells, and other immune cells detect and present antigens and respond by releasing proinflammatory mediators, such as IL-1β, IL-6 and TNF-α[,,48]. Goehler et al[] found that between the fibers of abdominal vagus there exist immune cells which can produce IL-1β. IL-1β acts to both coordinating the peripheral immune response and signaling the CNS[]. The globe cells of vagus paraganglia near liver hilus could be stained by biotinylated IL-1 receptor antagonist[] and by anti rat IL-1 receptor type I antibody[51], which suggested the possibility for vagus to sense the local IL-1. We[51] and others[] also have reported that the primary sensory neurons in nodose ganglia of vagus contain IL-1 receptor protein and mRNA, which indicates that vagus nerve probably can sense IL-1 directly. It is necessary to point out that vagus is definitely not the only route for immune signal getting into the brain, since it is found in the present study that although the number of STM stimulation-induced Fos expressed neurons in hypothalamus is attenuated after vagotomy, the number is still higher than that in control. So the humoral pathways or other nerves may also involve in the immune signals transmission in some degree, which still needs further study. Our results also showed that subdiagphragmatic vagotomy itself decreased the percentages of CD8+ T cells and MIFs of CD4+ and CD8+ T cells, which indicated the importance of intact vagus in maintaining the host immune balance. This is also accordant with our previous study[53]. As we know that CD4+ and CD8+ T cells are necessary in clearing STM[,,]. Vagotomy inhibits the subpopulation of T cells, which is a disadvantage to STM clearance and only aggravate the inhibition to CD4+ and CD8+ T cells induced by STM. How does the vagus influence the phenotype of lymphatic cells? Vagus contains both afferent and efferent fibers innervating abdomen. The former can transmit abdominal information into CNS and the latter innervates some immune organs or immune cells, such as abdominal lymph node. When we cut off subdiagphragmatic vagotomy, on the one hand, the abdominal immune information can’t be transmitted into the brain; on the other hand, the brain can’t influence the abdominal immune organizations via vagus. We suppose that this is probably the answer. In summary, subdiagphragmatic vagus is able to signal immune information from abdomen into the brain and intact vagus is necessary in maintaining the host immune balance. FootnotesSupported by National Natural Science Foundation, No. 39830130 Edited by Hu DK References
1. Maier SF, Goehler LE, Fleshner M, Watkins LR. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci. 1998;840:289–300. [PubMed] [Google Scholar]
2. Goehler LE, Gaykema RP, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci. 2000;85:49–59. [PubMed] [Google Scholar]
3. Dantzer R, Konsman JP, Bluthé RM, Kelley KW. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci. 2000;85:60–65. [PubMed] [Google Scholar]
4. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review & amp; analysis of alternative mechanisms. Life Sci. 1995;57:1011–1026. [PubMed] [Google Scholar]
5. Wang X, Wang BR, Ju G. The role of the vagus nerve in transmitting immune information into the brain. Shanghai Mianyixue Zazhi. 2000;20:192–194.[Google Scholar]
6. Lo WF, Ong H, Metcalf ES, Soloski MJ. T cell responses to Gram-negative intracellular bacterial pathogens: a role for CD8+ T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J Immunol. 1999;162:5398–5406. [PubMed] [Google Scholar]
7. Sagar SM, Sharp FR. Early response genes as markers of neuronal activity and growth factor action. Adv Neurol. 1993;59:273–284. [PubMed] [Google Scholar]
8. Xu ZC, Jiang XH. [Recent progress in the use of immediate early genes in neuroscience] Shengli Kexue Jinzhan. 1997;28:49–51. [PubMed] [Google Scholar]
9. Wang X, Wang BR, Duan XL, Ju G. The basal expression of Fos in the rat under the normal life situation. Zhongguo Shenjing Jiepouxue Zazhi. 2000;16:353–358.[Google Scholar]
10. Matsunaga W, Miyata S, Takamata A, Bun H, Nakashima T, Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res. 2000;858:9–18. [PubMed] [Google Scholar]
11. Zhang X, Ju G. [Induction and visualization of c-fos oncogene--a new method reflecting the functional neural pathways] Shengli Kexue Jinzhan. 1991;22:299–303. [PubMed] [Google Scholar]
12. Arnold FJ, De Lucas Bueno M, Shiers H, Hancock DC, Evan GI, Herbert J. Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats. Neuroscience. 1992;51:377–390. [PubMed] [Google Scholar]
13. Imaki T, Shibasaki T, Hotta M, Demura H. Intracerebroventricular administration of corticotropin-releasing factor induces c-fos mRNA expression in brain regions related to stress responses: comparison with pattern of c-fos mRNA induction after stress. Brain Res. 1993;616:114–125. [PubMed] [Google Scholar]
14. Morgan JI, Cohen DR, Hempstead JL, Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 1987;237:192–197. [PubMed] [Google Scholar]
15. Hare AS, Clarke G, Tolchard S. Bacterial lipopolysaccharide-induced changes in FOS protein expression in the rat brain: correlation with thermoregulatory changes and plasma corticosterone. J Neuroendocrinol. 1995;7:791–799. [PubMed] [Google Scholar]
16. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–462. [PubMed] [Google Scholar]
17. Ericsson A, Arias C, Sawchenko PE. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci. 1997;17:7166–7179. [PubMed] [Google Scholar]
18. Ivanov AI, Kulchitsky VA, Sugimoto N, Simons CT, Romanovsky AA. Does the formation of lipopolysaccharide tolerance require intact vagal innervation of the liver? Auton Neurosci. 2000;85:111–118. [PubMed] [Google Scholar]
19. Downing JE, Miyan JA. Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease. Immunol Today. 2000;21:281–289. [PubMed] [Google Scholar]
20. Roth J, De Souza GE. Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res. 2001;34:301–314. [PubMed] [Google Scholar]
21. Watkins LR, Maier SF. Implications of immune-to-brain communication for sickness and pain. Proc Natl Acad Sci USA. 1999;96:7710–7713.[PMC free article] [PubMed] [Google Scholar]
22. Shanks N, Windle RJ, Perks PA, Harbuz MS, Jessop DS, Ingram CD, Lightman SL. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci USA. 2000;97:5645–5650.[PMC free article] [PubMed] [Google Scholar]
23. Ling YL, Meng AH, Zhao XY, Shan BE, Zhang JL, Zhang XP. Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol. 2001;7:667–671.[PMC free article] [PubMed] [Google Scholar]
24. Romanovsky AA. Thermoregulatory manifestations of systemic inflammation: lessons from vagotomy. Auton Neurosci. 2000;85:39–48. [PubMed] [Google Scholar]
25. Blatteis CM, Li S. Pyrogenic signaling via vagal afferents: what stimulates their receptors? Auton Neurosci. 2000;85:66–71. [PubMed] [Google Scholar]
26. Layé S, Bluthé RM, Kent S, Combe C, Médina C, Parnet P, Kelley K, Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol. 1995;268:R1327–R1331. [PubMed] [Google Scholar]
27. Hansen MK, Taishi P, Chen Z, Krueger JM. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci. 1998;18:2247–2253. [PubMed] [Google Scholar]
28. Gaykema RP, Dijkstra I, Tilders FJ. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion. Endocrinology. 1995;136:4717–4720. [PubMed] [Google Scholar]
29. Kapcala LP, He JR, Gao Y, Pieper JO, DeTolla LJ. Subdiaphragmatic vagotomy inhibits intra-abdominal interleukin-1 beta stimulation of adrenocorticotropin secretion. Brain Res. 1996;728:247–254. [PubMed] [Google Scholar]
30. Sehic E, Blatteis CM. Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs. Brain Res. 1996;726:160–166. [PubMed] [Google Scholar]
31. Gaykema RP, Goehler LE, Tilders FJ, Bol JG, McGorry M, Fleshner M, Maier SF, Watkins LR. Bacterial endotoxin induces fos immunoreactivity in primary afferent neurons of the vagus nerve. Neuroimmunomodulation. 1998;5:234–240. [PubMed] [Google Scholar]
32. Luheshi GN, Bluthé RM, Rushforth D, Mulcahy N, Konsman JP, Goldbach M, Dantzer R. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci. 2000;85:127–132. [PubMed] [Google Scholar]
33. Romanovsky AA, Simons CT, Székely M, Kulchitsky VA. The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol. 1997;273:R407–R413. [PubMed] [Google Scholar]
34. Watkins LR, Wiertelak EP, Goehler LE, Smith KP, Martin D, Maier SF. Characterization of cytokine-induced hyperalgesia. Brain Res. 1994;654:15–26. [PubMed] [Google Scholar]
35. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res. 1995;692:244–250. [PubMed] [Google Scholar]
36. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst. 1996;61:287–291. [PubMed] [Google Scholar]
37. Gordon FJ. Effect of nucleus tractus solitarius lesions on fever produced by interleukin-1beta. Auton Neurosci. 2000;85:102–110. [PubMed] [Google Scholar]
38. Berthoud HR, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci. 2000;85:1–17. [PubMed] [Google Scholar]
39. Dou DB, Cai G. Regulation of the stomach motility function. Shijie Huaren Xiaohua Zazhi. 1999;7:353–354.[Google Scholar]
40. Niedergang F, Sirard JC, Blanc CT, Kraehenbuhl JP. Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors. Proc Natl Acad Sci USA. 2000;97:14650–14655.[PMC free article] [PubMed] [Google Scholar]
41. Garcia-del Portillo F, Finlay BB. Salmonella invasion of nonphagocytic cells induces formation of macropinosomes in the host cell. Infect Immun. 1994;62:4641–4645.[PMC free article] [PubMed] [Google Scholar]
42. Cookson BT, Bevan MJ. Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol. 1997;158:4310–4319. [PubMed] [Google Scholar]
43. Weinstein DL, Carsiotis M, Lissner CR, O'Brien AD. Flagella help Salmonella typhimurium survive within murine macrophages. Infect Immun. 1984;46:819–825.[PMC free article] [PubMed] [Google Scholar]
44. Tite JP, Dougan G, Chatfield SN. The involvement of tumor necrosis factor in immunity to Salmonella infection. J Immunol. 1991;147:3161–3164. [PubMed] [Google Scholar]
45. Nauciel C. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J Immunol. 1990;145:1265–1269. [PubMed] [Google Scholar]
46. Yang H, Wang L, Ju G. Evidence for hypothalamic paraventricular nucleus as an integrative center of neuroimmunomodulation. Neuroimmunomodulation. 1997;4:120–127. [PubMed] [Google Scholar]
47. Goehler LE, Gaykema RP, Nguyen KT, Lee JE, Tilders FJ, Maier SF, Watkins LR. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci. 1999;19:2799–2806. [PubMed] [Google Scholar]
48. Xia B. Pathogeny and mechanism of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi. 2001;9:245–250.[Google Scholar]
49. Maier SF, Wiertelak EP, Martin D, Watkins LR. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 1993;623:321–324. [PubMed] [Google Scholar]
50. Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, Maier SF, Watkins LR. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull. 1997;43:357–364. [PubMed] [Google Scholar]
51. Wang X, Wang BR, Duan XL, Liu HL, Ju G. The expression of IL-1receptor type I in nodose ganglion and vagal paraganglion in the rat. Zhongguo Shenjing Kexue Zazhi. 2000;16:90–93.[Google Scholar]
52. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 1998;18:9471–9479. [PubMed] [Google Scholar]
53. Wang X, Cao YX, Wang BR, Xu Z, Jin L, Duan XL, Ju G. The influence of subdiaphragmatic vagotomy on CD4 /CD8 T cells in peripheral blood. Xibao Fenzi Yu Mianyixue Zazhi. 2000;16:230–231.[Google Scholar]
54. McSorley SJ, Cookson BT, Jenkins MK. Characterization of CD4+ T cell responses during natural infection with Salmonella typhimurium. J Immunol. 2000;164:986–993. [PubMed] [Google Scholar]
55. Pie S, Truffa-Bachi P, Pla M, Nauciel C. Th1 response in Salmonella typhimurium-infected mice with a high or low rate of bacterial clearance. Infect Immun. 1997;65:4509–4514.[PMC free article] [PubMed] [Google Scholar]
Articles from World Journal of Gastroenterology are provided here courtesy of Baishideng Publishing Group Inc
0 Comments
Leave a Reply. |